A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone
Crossref DOI link: https://doi.org/10.1186/1755-8794-7-35
Published Online: 2014-06-17
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verschuren, Lars
Wielinga, Peter Y
Kelder, Thomas
Radonjic, Marijana
Salic, Kanita
Kleemann, Robert
van Ommen, Ben
Kooistra, Teake
License valid from 2014-06-17